Focus Partners Wealth
BIIB icon

Focus Partners Wealth’s Biogen BIIB Stock Holding History

Focus Partners Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.85M Buy
20,982
+6,401
+44% +$1.18M ﹤0.01% 1033
2025
Q4 		$2.57M Buy
14,581
+4,664
+47% +$762K ﹤0.01% 1216
2025
Q3 		$1.41M Buy
9,917
+3,209
+48% +$434K ﹤0.01% 1151
2025
Q2 		$843K Sell
6,708
-3,465
-34% -$432K ﹤0.01% 1217
2025
Q1 		$1.39M Buy
10,173
+6,395
+169% +$914K ﹤0.01% 955
2024
Q4 		$578K Buy
3,778
+1,061
+39% +$179K ﹤0.01% 1265
2024
Q3 		$422K Buy
2,717
+1,485
+121% +$311K ﹤0.01% 1203
2024
Q2 		$286K Buy
+1,232
New +$268K ﹤0.01% 1079

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Focus Partners Wealth's BIIB Position: Q1 2026 in Review

Focus Partners Wealth increased its Biogen (BIIB) stake by 44% in Q1 2026, buying an estimated $1.18M and bringing the position to 20,982 shares worth $3.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1033.

Focus Partners Wealth first reported a position in BIIB in Q2 2024 and has held it in 8 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Focus Partners Wealth held 20,982 shares of Biogen worth $3.85M as of Q1 2026.
  • Focus Partners Wealth bought 6,401 Biogen shares in Q1 2026, an estimated $1.18M.
  • Biogen made up ﹤0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #1033 holding.
  • Focus Partners Wealth first reported a position in Biogen in Q2 2024 and has held it in 8 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.